We have announced the successful closing of our new seed fund, Supernova Innovation 3, at its €100 million target. The fund earned the renewed confidence of its long-standing investors — including CEA, several regional Crédit Agricole branches, VINCI, Michelin, bioMérieux, and the French National Seed Fund #2 (FNA2), managed on behalf of the French government by Bpifrance as part of the France 2030 initiative. They have been joined by new partners such as Orano, MACSF, Agir à Dom, and Groupe Seb.
We are delighted with the continued commitment from our existing investors and honored to have earned the trust of such high-profile new backers. In this context, reaching our fund size objective is a real point of pride. This fund strengthens our historical position in seed investing and will be one of the largest of its kind in France. Launching a fund of this scale was essential to support the most promising deeptech startups in France and Europe, particularly in our key focus areas”, said Celia Hart, General Partner and Head of Seed Investment at Supernova Invest.
One of the Largest Deeptech Seed Funds in France — Already in Action
With this new fund, Supernova Invest reinforces its historic leadership in deeptech seed funding. Through previous vehicles — including Supernova 2 — the firm has invested in 20 high-potential companies such as Carthera, Scintil, Mirsense, and Adionics. Collectively, these startups have raised over €330 million, filed more than 150 patents, and created over 400 jobs.
Despite a challenging macroeconomic environment, reaching the fund’s hard cap once again underscores the growing interest from both private and institutional investors in the deeptech asset class — driven by its transformational impact and strong roots in scientific research. Supernova Invest stands out for its ability to support pioneering companies through all stages of growth — from seed to exit — across strategic sectors such as advanced materials, medical devices, semiconductors, quantum technologies, and energy transition.
This operation also highlights the team’s unique expertise in early-stage investing. A team of nine Supernova Invest investors will manage the multi-sectoral fund, which aims to invest in around 20 new portfolio companies. Five investments have already been made:
• Quobly (quantum co-processors on silicon)
• Stellaria (modular nuclear reactors)
• Discure (disc disease treatments)
• Allotex (biocompatible implants for presbyopia)
• Wattalps (batteries for heavy electric vehicles)
“With this new fund, Supernova Invest strengthens its leadership in European deeptech. Our team will continue building out our investment platform to ambitiously support revolutionary technology companies aiming to become global industrial champions — from inception to scale. Providing this continuum of financing, which the French and European ecosystems so urgently need, will remain at the heart of our mission,” added Pierre-Emmanuel Struyven, President of Supernova Invest.
